Establishment of murine model for auto immune hepatitis (AIH)
Establishment of murine model for auto immune hepatitis (AIH)
批准号:
14570523
负责人:
OKUMURA Akihiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background : We established murine hepatitis model by immunizing mice with human P450IID6 (CYP2D6), the target molecule of LKM-1 antibody. In the present study, we investigated the mechanism of liver cell injury in AIH, including the dynamics of T-reg, using our murine hepatitis model. Materials and methods : Eight week old C57BL/6 male mice were immunized with β-gal-CYP2D6 (0.1μmol), the fusion protein of β-gal and CYP2D6, intraperitoneally. Serum levels of ALT and anti-CYP2D6, and histologic changes in the liver were tested weekly until 4 week after immunization. To determine the proportion of CD4^+-T cell, CD8^+-T cell, and T-reg, liver infiltrating lymphocytes (LIL) and splenocytes (SP) were collected, stained with anti-CD4-PE in combination with anti-CD8-FITC or anti-CD25-FITC, and run on FACS flow cytometer, collecting data on 1x10^4 cells, analyzed using Cell Quest software. Results : Serum ALT level reached the peak at 2 week after immunization and returned to normal level at 4 … More week in the mice immunized with β-gal-CYP2D6. Histologically, periportal infiltration of the inflammatory cells and focal necrosis in the lobule was observed in the livers of the β-gal-CYP2D6-immunized mice. When LIL were used for the FACS analysis, the ratio of CD4/CD8 decreased at 1 week after immunization, synchronized with the elevation of ALT levels, then recovered gradually in parallel with the resolution of ALT flare. When SP were used, however, the change of CD4/CD8 was marginal, indicating the different dynamics of CD4^+- and CD8^+-T cells in SP from that in LIL during the course of hepatitis. The frequency of CD4^+ CD25^+-T cell (T-reg) in SP were similar to LIL. The frequency of T-reg in LIL decreased immediately at 1 week after immunization, and gradually increased to the same level as pre-immunization. T-reg in SP decreased more slowly than that in LIL, reached minimum at 2 week after immunization, then increased similarly to T-reg in LIL. Conclusions : Immunization of C57BL/6 mice with β-gal-CYP2D6 resulted in inflammation in the liver. Our results using FACS analysis indicated the predominance of CD8^+T cells in the livers with hepatitis. Further, the frequency of T-reg changed drastically during the flare of ALT levels, implies the possibility that T-reg play some roles on the course of hepatitis. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of novel therapeutic approach through regulatory T cells (Tr) and dendritic cells (DCs) for the patients with autoimmune hepatitis (AIH)
-
批准号:18590754
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2006
-
负责人:OKUMURA Akihiko
-
依托单位:
Roles of regulatory T cells (Tr) and dendritic cells (DCs) in the pathogenesis of autoimmune hepatitis(AIH)
-
批准号:16590644
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:OKUMURA Akihiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于人工智能-生理药动学探究阿塞那平与CYP2D6底物的药物相互作用及个体化给药方案
-
批准号:2025JJ80180
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:谢茜
-
依托单位:
中药前胡中水合氧化前胡素代谢活化共价修饰CYP2D6致酶失活的机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘英
-
依托单位:
新型细胞色素P450 2D6(CYP2D6)变异体的功能及其酶动力学特征研究
-
批准号:LTGC23H310001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:钱建畅
-
依托单位:
探索锌离子在人CYP2D6 药物代谢过程中的作用机制
-
批准号:2021JJ30101
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:郑何平
-
依托单位:
人细胞色素CYP2D6基因突变致云南及周边国家伯氨喹根治间日疟失败的遗传关联性研究
-
批准号:82160637
-
项目类别:地区科学基金项目
-
资助金额:35.00万元
-
批准年份:2021
-
负责人:董莹
-
依托单位:
细胞色素P450酶2D6(CYP2D6)新变异体功能改变的分子机理与临床表型研究
-
批准号:81973397
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:胡国新
-
依托单位:
中国人群肝脏代谢酶CYP2D6基因型和代谢表型的关系研究
-
批准号:81503162
-
项目类别:青年科学基金项目
-
资助金额:17.9万元
-
批准年份:2015
-
负责人:陈锐
-
依托单位:
CYP2D6基因在维吾尔族人群的多态性分布规律及代谢表型差异
-
批准号:31100898
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:李树春
-
依托单位:
基于CYP2D6活性部位关键氨基酸残基的药物代谢研究
-
批准号:81041113
-
项目类别:专项基金项目
-
资助金额:11.0万元
-
批准年份:2010
-
负责人:乔海灵
-
依托单位:
自身免疫性肝炎中CYP2D6抗原表位识别的研究
-
批准号:39570673
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:1995
-
负责人:仲人前
-
依托单位: